Mikele Bicolli
Patent Analyst
Joined Patexia at May 12, 2021
Patent Analyst at Patexia Inc
Mikele Bicolli
Mar 11, 2025
Patent Litigation
The U.S. Patent and Trademark Office (USPTO) is set for a leadership change as President Donald Trump has nominated John Squires to serve as the next Director. Squires, a veteran intellectual property attorney with experience in both corporate and private practice, brings a background in patent law, financial technology, and... Read More
Mikele Bicolli
Jul 20, 2024
Patent Litigation
Huawei Technologies has recently taken legal action against MediaTek, alleging patent infringement. The lawsuit, filed in a Chinese court, is part of Huawei's broader strategy to enhance revenue through licensing fees and royalties. MediaTek, a prominent supplier of application processors for smartphones and other consumer electronics, acknowledged the lawsuit but... Read More
Mikele Bicolli
Jun 19, 2024
Patent Litigation
In a landmark decision, Amazon has been ordered to pay nearly $122 million to AlmondNet Inc. for infringing on patents related to targeted internet advertising technology. The case, tried in the U.S. District Court for the Western District of Texas, revolved around two patents owned by AlmondNet that cover "privacy-friendly,... Read More
Mikele Bicolli
In a strategic legal move, Samsung has filed a lawsuit against Finnish startup Oura Health Oy, aiming to prevent the company from suing over the impending launch of the Galaxy Ring. This proactive step underscores the complex dynamics of intellectual property (IP) disputes in the tech industry, where larger corporations often... Read More
Mikele Bicolli
In a significant legal ruling, semiconductor Micron Technology has been ordered to pay $445 million to competitor Netlist Inc. for patent infringement. The jury's decision, delivered by the U.S. District Court for the Eastern District of Texas, found Micron guilty of willfully infringing on two of Netlist’s patents related to... Read More
Mikele Bicolli
Moderna recently registered a significant triumph in its ongoing patent dispute concerning its Covid-19 vaccine against Pfizer and BioNTech. The European Patent Office (EPO) upheld the legitimacy of a key Moderna patent in an oral verdict, boosting the company's stance in its legal battle. The validated patent, known as the... Read More